ZIKA-001: Safety and Immunogenicity of an Engineered DNA Vaccine Against ZIKA virus infection

BACKGROUND: While Zika virus (ZIKV) infection is typically self-limited, congenital birth defects and Guillain-Barré syndrome are well-described. There are no therapies or vaccines against ZIKV infection. METHODS: ZIKA-001 is a phase I, open label, clinical trial designed to evaluate the safety, sid...

Full description

Saved in:
Bibliographic Details
Published in:Open Forum Infect Dis
Main Authors: Tebas, Pablo, Roberts, Christine C, Muthumani, Kar, Reuschel, Emma, White, Scott, Khan, Amir S, Racine, Trina, Choi, Hyeree, Zaidi, Faraz, Boyer, Jean, Kudchodkar, Sagar, Park, Young K, Trottier, Sylvie, Remigio, Celine, Krieger, Diane, Kobinger, Gary P, Weiner, David, Maslow, Joel
Format: Artigo
Language:Inglês
Published: Oxford University Press 2017
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5631827/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofx163.693
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items